Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Medullary thyroid carcinoma: prognostic factors

D A Riddell1, H B Lampe, H Cramer

  • 1Department of Otolaryngology, University of Western Ontario, London, Canada.

The Journal of Otolaryngology
|June 1, 1993
PubMed
Summary

Medullary thyroid carcinoma prognosis was evaluated using epidemiologic and immunohistochemical factors. Stage, age at onset, DNA ploidy, and BRST-1 staining significantly predict patient outcomes in this rare thyroid cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A randomized controlled trial of acupuncture and receptive music therapy for sleep disorders in the elderly-ELAMUS: study protocol.

BMC complementary medicine and therapies·2024
Same author

Homeopathy for seasonal allergic rhinitis: rationale, design and methods of the three-armed randomized controlled HOMEOSAR trial.

BMC complementary medicine and therapies·2022
Same author

Efficacy of Persian barley water on clinical outcomes of hospitalized moderate-severity COVID-19 patients: a single-blind, add-on therapy, randomized controlled clinical trial.

European review for medical and pharmacological sciences·2022
Same author

Evidence on yoga for health: A bibliometric analysis of systematic reviews.

Complementary therapies in medicine·2021
Same author

Pathways to post-traumatic growth in cancer patients: moderated mediation and single mediation analyses with resilience, personality, and coping strategies.

Journal of affective disorders·2020
Same author

Understanding and optimising patient and public involvement in trial oversight: an ethnographic study of eight clinical trials.

Trials·2020

Area of Science:

  • Oncology
  • Endocrinology
  • Pathology

Background:

  • Medullary thyroid carcinoma (MTC) is a rare neuroendocrine tumor arising from calcitonin-producing cells in the thyroid.
  • MTC exhibits intermediate aggressiveness compared to well-differentiated and anaplastic thyroid cancers.
  • Understanding prognostic factors is crucial for managing MTC patients.

Purpose of the Study:

  • To retrospectively analyze prognostic indicators in medullary thyroid carcinoma.
  • To identify key epidemiologic, immunohistochemical, and genetic factors influencing MTC outcomes.

Main Methods:

  • Retrospective analysis of 18 medullary thyroid carcinoma patients.
  • Evaluation of epidemiologic factors: stage, age at onset, sex, heredity.
  • Assessment of immunohistochemical markers: Leu-M1, calcitonin, thyroglobulin, somatostatin, CEA, NSE, BRST-1.

Related Experiment Videos

  • Determination of DNA ploidy via flow cytometry.

    • Main Results:

    • Stage, age at onset, DNA ploidy, and BRST-1 staining were significant prognostic factors.
    • These factors demonstrated predictive value for patient outcomes in medullary thyroid carcinoma.

    Conclusions:

    • Specific clinical, pathological, and genetic parameters can predict medullary thyroid carcinoma prognosis.
    • BRST-1 immunohistochemistry and DNA ploidy analysis are valuable additions to prognostic assessment for MTC.